Pages that link to "Q53588985"

The following pages link to Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features. (Q53588985):

Displaying 24 items.

• Multifarious proteomic signatures and regional heterogeneity in glioblastomas (Q33409559) (← links)
• Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update (Q33805874) (← links)
• DNA hypomethylation in cancer cells (Q33862334) (← links)
• S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer (Q34394796) (← links)
• UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. (Q35050488) (← links)
• Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile. (Q35096197) (← links)
• Ubiquitin C-terminal hydrolase l1 in tumorigenesis (Q36091119) (← links)
• The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer (Q36221083) (← links)
• DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer (Q36300261) (← links)
• Molecular biology of gallbladder cancer: potential clinical implications (Q36352240) (← links)
• Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma (Q37415914) (← links)
• Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. (Q37424550) (← links)
• Epigenetic changes in carcinogenesis of gallbladder (Q37471592) (← links)
• Emerging roles of deubiquitinases in cancer-associated pathways (Q37674364) (← links)
• Potential biomarkers in gallbladder cancer: present status and future directions (Q38038882) (← links)
• Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1. (Q38108538) (← links)
• Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers (Q38844664) (← links)
• CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer (Q38855817) (← links)
• Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation (Q39019302) (← links)
• Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance (Q39533559) (← links)
• Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. (Q39955983) (← links)
• Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma (Q51788839) (← links)
• Overexpression of ubiquitin carboxyl terminal hydrolase impairs multiple pathways during eye development in Drosophila melanogaster. (Q52736642) (← links)
• Targeting DNA Hypomethylation in Malignancy by Epigenetic Therapies (Q90429907) (← links)